title: Prenatal cocaine exposure causes sex-dependent impairment in the myogenic reactivity of coronary arteries in adult offspring.
abstract: Cocaine abuse is a significant problem among pregnant women. The present study tested the hypothesis that prenatal cocaine exposure impairs myogenic reactivity of coronary arteries in adult offspring. Pregnant rats received cocaine (30 mg kg(-1) day(-1)) or saline from days 15 to 21 of gestational age, and experiments were conducted in 3-month-old offspring. In pressurized coronary septal arteries, the diameter and vessel wall intracellular Ca2+ concentrations were measured simultaneously in the same tissue as a function of intraluminal pressure. Cocaine did not affect KCl-induced contractions of coronary arteries in either males or females but decreased the distensibility in male vessels. In male offspring, cocaine treatment resulted in a significant decrease in pressure-dependent myogenic contractions. Inhibition of eNOS with NG-nitro-L-arginine did not alter the myogenic response in either saline control or cocaine-treated animals. In females, cocaine caused a significant increase in pressure-dependent myogenic contractions. NG-nitro-L-arginine did not affect the myogenic response in the control animals but blocked the cocaine-mediated effect. In both males and females, the pressure-induced increases in vessel wall Ca2+ concentrations were not significantly different between cocaine and saline groups. The ratio of changes in the diameter to Ca2+ concentrations in the pressurized arteries was significantly less in male but greater in female offspring after cocaine treatment. The results suggest that prenatal cocaine exposure causes reprogramming of coronary myogenic tone via changes in the Ca2+ sensitivity in a sex-dependent manner, leading to an increased risk of dysfunction of coronary autoregulation in adult offspring.
authors.affiliation: Center for Perinatal Biology, Department of Physiology and Pharmacology, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
authors.forename: DaLiao
authors.initials: D
authors.lastname: Xiao
authors.forename: Shumei
authors.initials: S
authors.lastname: Yang
authors.forename: Lubo
authors.initials: L
authors.lastname: Zhang
mesh_terms: D000818:Animals; D003042:Cocaine / Q000633:toxicity*; D019970:Cocaine-Related Disorders; D003331:Coronary Vessels / Q000187:drug effects* / Q000503:physiopathology; D005260:Female; D047109:Fetal Development / Q000187:drug effects; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000503:physiopathology; D011247:Pregnancy; D011248:Pregnancy Complications; D011297:Prenatal Exposure Delayed Effects; D011336:Probability; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D012307:Risk Factors; D012680:Sensitivity and Specificity; D012737:Sex Factors; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D003042:Cocaine
references.citation: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2224-37
references.pmid: 12003832
references.citation: Physiol Rev. 2005 Apr;85(2):571-633
references.pmid: 15788706
references.citation: J Pediatr. 1991 Jan;118(1):44-51
references.pmid: 1986097
references.citation: J Appl Physiol (1985). 2004 Jul;97(1):404-15
references.pmid: 15220323
references.citation: Int J Cardiol. 2004 Nov;97(2):225-32
references.pmid: 15458688
references.citation: Circulation. 2000 Mar 21;101(11):1303-10
references.pmid: 10725291
references.citation: Cardiovasc Res. 2003 Nov 1;60(2):228-34
references.pmid: 14613851
references.citation: Cardiovasc Res. 2003 Oct 1;59(4):834-43
references.pmid: 14553823
references.citation: Trends Endocrinol Metab. 2002 Nov;13(9):364-8
references.pmid: 12367816
references.citation: Am J Physiol Heart Circ Physiol. 2006 Mar;290(3):H1081-9
references.pmid: 16214843
references.citation: J Pharmacol Exp Ther. 2007 Feb;320(2):654-61
references.pmid: 17068201
references.citation: Hypertension. 2009 Aug;54(2):352-8
references.pmid: 19528364
references.citation: J Mol Cell Cardiol. 2007 Feb;42(2):326-32
references.pmid: 17217956
references.citation: Antioxid Redox Signal. 2008 Jun;10(6):1115-26
references.pmid: 18321209
references.citation: Lancet. 1993 Apr 10;341(8850):938-41
references.pmid: 8096277
references.citation: J Pharmacol Exp Ther. 2009 Jan;328(1):99-106
references.pmid: 18952886
references.citation: Am J Physiol Heart Circ Physiol. 2000 May;278(5):H1490-9
references.pmid: 10775126
references.citation: Biol Reprod. 2005 Apr;72(4):997-1003
references.pmid: 15601918
references.citation: J Physiol. 2005 May 15;565(Pt 1):149-58
references.pmid: 15677681
references.citation: Biol Reprod. 2009 Mar;80(3):440-8
references.pmid: 18945988
references.citation: Hypertension. 2009 Jun;53(6):937-43
references.pmid: 19380615
references.citation: Cardiovasc Res. 2008 Jan;77(1):8-18
references.pmid: 17764667
references.citation: Cardiovasc Res. 2009 Apr 1;82(1):9-20
references.pmid: 19179352
references.citation: Ann Med. 2008;40(3):180-96
references.pmid: 18382884
references.citation: Can J Physiol Pharmacol. 2007 Aug;85(8):818-22
references.pmid: 17901892
references.citation: Cardiovasc Res. 2004 Feb 1;61(2):317-24
references.pmid: 14736548
references.citation: Am J Physiol Regul Integr Comp Physiol. 2005 Oct;289(4):R1169-76
references.pmid: 15961529
references.citation: Am J Physiol Heart Circ Physiol. 2005 Aug;289(2):H674-82
references.pmid: 15833805
references.citation: Circulation. 1994 Jul;90(1):204-12
references.pmid: 8025998
references.citation: Physiol Rev. 2006 Oct;86(4):1263-308
references.pmid: 17015490
references.citation: J Am Coll Cardiol. 1996 Nov 1;28(5):1154-60
references.pmid: 8890809
references.citation: Hypertension. 2008 Apr;51(4):1239-47
references.pmid: 18259024